[HTML][HTML] Effectiveness of molnupiravir treatment in patients with COVID-19 in Korea: a propensity score matched study
HR Park, MG Yoo, JM Kim, SJ Bae, H Lee… - Infection & …, 2023 - ncbi.nlm.nih.gov
Background The MOVe-OUT (efficacy and safety of molnupiravir [MK-4482] in non-
hospitalized adult participants with COVID-19 [MK-4482-002]) trial reported that the …
hospitalized adult participants with COVID-19 [MK-4482-002]) trial reported that the …
[HTML][HTML] Safety and Effectiveness of Molnupiravir in Japanese Patients with COVID-19: Final Report of Post-Marketing Surveillance in Japan
S Shinozaki, A Watanabe, M Kimata… - Infectious Diseases and …, 2024 - Springer
Introduction Molnupiravir is an orally available prodrug of N-hydroxycytidine that received
special approval for emergency treatment of coronavirus disease 2019 (COVID-19) in Japan …
special approval for emergency treatment of coronavirus disease 2019 (COVID-19) in Japan …
Non-randomized evaluation of hospitalization after a prescription for nirmatrelvir/ritonavir versus molnupiravir in high-risk COVID-19 outpatients
K Cowman, A Miller, Y Guo, MH Chang… - Journal of …, 2023 - academic.oup.com
Objectives To assess and compare subsequent hospital admissions within 30 days for
patients after receiving a prescription for either oral nirmatrelvir/ritonavir or oral molnupiravir …
patients after receiving a prescription for either oral nirmatrelvir/ritonavir or oral molnupiravir …
[HTML][HTML] Hospitalization among patients treated with molnupiravir: A retrospective study of administrative data
G Prajapati, A Das, Y Sun, E Fonseca - Clinical Therapeutics, 2023 - Elsevier
Purpose Molnupiravir is an oral antiviral agent authorized for emergency use to treat mild to
moderate cases of coronavirus disease 2019 (COVID-19) in adults at high risk for …
moderate cases of coronavirus disease 2019 (COVID-19) in adults at high risk for …
Effectiveness of nirmatrelvir/ritonavir and molnupiravir in non-hospitalized adults with COVID-19: systematic review and meta-analysis of observational studies
Objective To determine the effectiveness of nirmatrelvir/ritonavir and molnupiravir among
vaccinated and unvaccinated non-hospitalized adults with COVID-19. Methods …
vaccinated and unvaccinated non-hospitalized adults with COVID-19. Methods …
Outpatient Treatment of Confirmed COVID-19: A Living, Rapid Evidence Review for the American College of Physicians (Version 2, Update Alert)
This first update alert reports surveillance results of the living, rapid evidence review on
“Outpatient Treatment of Confirmed COVID-19: A Living, Rapid Evidence Review for the …
“Outpatient Treatment of Confirmed COVID-19: A Living, Rapid Evidence Review for the …
[HTML][HTML] Pathogenic mechanisms of cardiovascular damage in COVID-19
HH Shao, RX Yin - Molecular Medicine, 2024 - Springer
Background COVID-19 is a new infectious disease caused by the severe acute respiratory
syndrome coronavirus 2 (SARS CoV-2). Since the outbreak in December 2019, it has …
syndrome coronavirus 2 (SARS CoV-2). Since the outbreak in December 2019, it has …
[HTML][HTML] Perceived Risk for Severe COVID-19 and Oral Antiviral Use Among Antiviral-Eligible US Adults
K Penrose, A Srivastava, Y Shen… - Infectious Diseases and …, 2024 - Springer
Introduction Oral antiviral medications are important tools for preventing severe COVID-19
outcomes. However, their uptake remains low for reasons that are not entirely understood …
outcomes. However, their uptake remains low for reasons that are not entirely understood …
[HTML][HTML] Mismanagement of SARS-CoV-2 Infection Pre Hospitalisation during the Omicron Era: Antibiotics and Steroids Instead of Early Antivirals
A Giacomelli, CL Ciubotariu, M Zacheo, A Rabbione… - Viruses, 2024 - mdpi.com
The aim of this study was to assess the prevalence of inappropriate treatment among
hospitalised patients affected by SARS-CoV-2 infection before hospital admission during the …
hospitalised patients affected by SARS-CoV-2 infection before hospital admission during the …
Effectiveness and Safety of Molnupiravir in the Intended-Use Population: an Observational Cohort Study
Objectives Previous research reported inconsistent results on the efficacy of molnupiravir in
treating COVID-19. Moreover, efficacy was not assessed in the intended-use population …
treating COVID-19. Moreover, efficacy was not assessed in the intended-use population …